Stable IgG-antibody levels in patients with mild SARS-CoV-2 infectionShow others and affiliations
2021 (English)In: MedrxivArticle in journal (Refereed) Published
Abstract [en]
More knowledge regarding persistence of antibody response to SARS-CoV-2 infections in the general population with mild symptoms is needed. We measured and compared levels of SARS CoV-2 spike- and nucleocapsid-specific IgG-antibodies in serum samples from 145 laboratory confirmed COVID-19 cases and 324 non-cases. The IgG-antibody levels against the spike protein in cases were stable over the time-period studied (14 to 256 days), while antibody levels against the nucleocapsid protein decreased over time
Place, publisher, year, edition, pages
2021.
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:ri:diva-56949DOI: 10.1101/2021.06.16.21258960OAI: oai:DiVA.org:ri-56949DiVA, id: diva2:1612702
Note
This project was exclusively funded by the Public Health Agency of Sweden via an assignment (S2020_05026) from the Ministry of Health and Social Affairs, Government of Sweden.
2021-11-192021-11-192023-12-07Bibliographically approved